There are currently six transvaginal mesh multidistrict litigations (MDLs) being heard in West Virginia by Judge Joseph Goodwin. These six cases bring together thousands of lawsuits filed by women across the country who suffered injuries after being implanted with mesh devices. The latest report from the U.S. Joint Panel on Multidistrict Litigation C. R. Bard, 11,535 against American Medical Systems, 7,370 against Boston Scientific, 11,859 against Johnson & Johnson’s Ethicon, 1,133 against Coloplast and 136 against Cook Medical.
An unnecessary waste of resources and time that would ultimately result in an overall delay.
Now, though, plaintiffs who suffered complications from the Neomedic bladder sling are calling for the creation of a seventh MDL. Around 22 lawsuits are currently being heard in eight different courts across the United States, and the consolidation of these suits would, it’s argued, streamline the process and save time. Judge Goodwin’s experience with the six existing MDLs would no doubt also ensure that the Neomedic litigation proceeds as smoothly as possible. Lawsuits allege that the company’s Contasure Needless Sling and Remeex System vaginal mesh devices caused injuries and complications.
The JPML met at the end of last year to consider plaintiffs’ request for consolidation, but ended up declining to respond so soon. Since then, Neomedic has filed a motion asking the panel not to consolidate, calling it an “unnecessary waste” of resources and time that would “ultimately result in an overall delay” to the legal process. The company also claims that some of the lawsuits involve only a single plaintiff “implanted with multiple women’s pelvic repair products manufactured by different defendants, some of which have already been transferred.”
Neomedic, despite opposing the formation of an MDL, does at least admit that its products can cause injuries requiring corrective surgery.
If you’ve been injured by transvaginal mesh, or have something to say about this case, you can get in touch using the form on the right, or by leaving a comment below.